rs201974007

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001290043.2(TAP2):​c.1462-7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,611,262 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00086 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 4 hom. )

Consequence

TAP2
NM_001290043.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00005579
2

Clinical Significance

Likely benign criteria provided, single submitter B:4

Conservation

PhyloP100: 1.94

Publications

0 publications found
Variant links:
Genes affected
TAP2 (HGNC:44): (transporter 2, ATP binding cassette subfamily B member) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. This gene is located 7 kb telomeric to gene family member ABCB2. The protein encoded by this gene is involved in antigen presentation. This protein forms a heterodimer with ABCB2 in order to transport peptides from the cytoplasm to the endoplasmic reticulum. Mutations in this gene may be associated with ankylosing spondylitis, insulin-dependent diabetes mellitus, and celiac disease. Alternative splicing of this gene produces products which differ in peptide selectivity and level of restoration of surface expression of MHC class I molecules. [provided by RefSeq, Feb 2014]
TAP2 Gene-Disease associations (from GenCC):
  • MHC class I deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-32830447-A-G is Benign according to our data. Variant chr6-32830447-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 534719.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00086 (131/152282) while in subpopulation NFE AF = 0.00104 (71/68008). AF 95% confidence interval is 0.000848. There are 1 homozygotes in GnomAd4. There are 57 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAP2NM_001290043.2 linkc.1462-7T>C splice_region_variant, intron_variant Intron 8 of 11 ENST00000374897.4 NP_001276972.1 Q03519-1Q5JNW1
TAP2NM_018833.3 linkc.1462-7T>C splice_region_variant, intron_variant Intron 8 of 11 NP_061313.2 Q03519-2Q9UP03

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAP2ENST00000374897.4 linkc.1462-7T>C splice_region_variant, intron_variant Intron 8 of 11 1 NM_001290043.2 ENSP00000364032.3 Q03519-1
ENSG00000250264ENST00000452392.2 linkc.1462-7T>C splice_region_variant, intron_variant Intron 8 of 14 2 ENSP00000391806.2 E7ENX8

Frequencies

GnomAD3 genomes
AF:
0.000861
AC:
131
AN:
152164
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.0101
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00104
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00113
AC:
270
AN:
238990
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.000207
Gnomad AMR exome
AF:
0.00112
Gnomad ASJ exome
AF:
0.00825
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000141
Gnomad NFE exome
AF:
0.00124
Gnomad OTH exome
AF:
0.00202
GnomAD4 exome
AF:
0.00106
AC:
1546
AN:
1458980
Hom.:
4
Cov.:
36
AF XY:
0.00103
AC XY:
746
AN XY:
725738
show subpopulations
African (AFR)
AF:
0.000330
AC:
11
AN:
33382
American (AMR)
AF:
0.00102
AC:
45
AN:
44326
Ashkenazi Jewish (ASJ)
AF:
0.00824
AC:
215
AN:
26088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39632
South Asian (SAS)
AF:
0.000186
AC:
16
AN:
86064
European-Finnish (FIN)
AF:
0.000287
AC:
15
AN:
52260
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5762
European-Non Finnish (NFE)
AF:
0.00104
AC:
1155
AN:
1111136
Other (OTH)
AF:
0.00134
AC:
81
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
109
218
327
436
545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000860
AC:
131
AN:
152282
Hom.:
1
Cov.:
32
AF XY:
0.000766
AC XY:
57
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41564
American (AMR)
AF:
0.000523
AC:
8
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0101
AC:
35
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00104
AC:
71
AN:
68008
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00182
Hom.:
0
Bravo
AF:
0.00100

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

MHC class I deficiency Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

TAP2-related disorder Benign:1
Oct 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
9.4
DANN
Benign
0.67
PhyloP100
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000056
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201974007; hg19: chr6-32798224; API